%0 Generic
%A Reck, M.
%A Ciuleanu, T-E.
%A Cobo, M.
%A Schenker, M.
%A Zurawski, B.
%A Menezes, J.
%A Richardet, E.
%A Bennouna, J.
%A Cheng, Y.
%A Paz-Ares, L.
%A Lu, S.
%A John, T.
%A Padilla, B.
%A Sun, X.
%A Moisei, A.
%A Yan, J.
%A Yuan, Y.
%A Blum, S. I.
%A Carbone, D. P.
%T First-line nivolumab (NIVO) plus ipilimumab (IPI) combined with 2 cycles of platinum-based chemotherapy (chemo) vs 4 cycles of chemo in advanced non-small cell lung cancer (NSCLC): Patient-reported outcomes (PROs) from CheckMate 9LA
%D 2020
%@ 0923-7534
%U https://hdl.handle.net/10668/24352
%~